Is Immunonutrition Ready for Prime Time? Two Points of View

Nutrition in Clinical Practice

Volumn 18, Issue 6, 2003, Pages 489-496

  Martindale, Robert G ^a   Miles, John ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; NUCLEOTIDE DERIVATIVE; OMEGA 3 FATTY ACID;

CRITICAL ILLNESS; ELECTIVE SURGERY; ENTERIC FEEDING; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION RISK; NUTRITION; NUTRITIONAL STATUS; PARENTERAL NUTRITION; REVIEW;

EID: 0347533832     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426503018006489     Document Type: Review

References (65)

1. Kudsk KA, Moore F, Martindale RG, Cresci G, McClave S, Schloerb PR. Consensus recommendations from the U. S. summit on immune-enhancing enteral therapy. JPEN. 2001;25(suppl): S61-S62.
2. Schloerb PR. Immune-enhancing diets: products, components, and their rationales. JPEN. 2001;25(suppl):S3-S7.
3. Ochoa JB, Strange J, Kearney P, Gellin G, Endean E, Fitzpatrick E. Effects of L-arginine on the proliferation of T-lymphocyte subpopulations. JPEN. 2001;25:23-29.
4. Cerra FB, Lehmann S, Konstantinides N, et al. Improvement in immune function in ICU patients by enteral nutrition supplemented with arginine, RNA, and menhaden oil is independent of nitrogen balance. Nutrition. 1991;7:193-199.
5. Schmidt H, Martindale RG. Special nutrient formulas (neutraceuticals). In: Shikora SA, Marindale RG, Schwaitzberg SD, eds. Nutritional Considerations in the Intensive Care Unit. Dubuque, Iowa: Kendall/Hunt Publishing Co; 2002;357-364.
6. Sarubin A. The Health Professional's Guide to Popular Dietary Supplelments. Chicago, IL: American Dietetic Association; 2000.
7. Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg. 1998;208:512-522.
8. McCowen KC, Bistrian BR. Immunonutrition in critical illness. Nutr Clin Pract. 2002;17:265-266.
9. Ziegler TR, Benfell K, Smith RJ, et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN. 1990;14(suppl):137S-146S.
10. Houdijk APJ, Rijnsburger ER, Jansen J, et al. Randomized trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet. 1998;352:772-776.
11. Jones C, Palmer TEA, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition. 1999;15:1008-1115.
12. Calder PC, Deckelbaum RJ. Fats in the new millennium: more complexity but a better understanding? Curr Opin Clin Nutr Metab Care. 2001;4:89-91.
13. Angerer P, von Schacky C. ω-3 Polyunsaturated fatty acids and the cardiovascular system. Curr Opin Clin Nutr Metab Care. 2000;6:417-502.
14. Gottschlich MM, Jenkins M, Warden GD, et al. Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN. 1990;14:225-236.
15. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554.
16. Sax HC. Effect of immune enhancing formulas (IEF) in general surgery patients. JPEN. 2001;25(suppl):S19-S23.
17. Daly JM, Weinbraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995;221:327-338.
18. Braga M, Vagnali A, Gianotti L, Cestari A, Profili M, Di Carlo V. Benefits of early postoperative enteral feeding in cancer patients. Infusions Ther Transfusions Med. 1995;22:280-284.
19. Braga M, Gianotti, L, Vignali A, Cestari A, Bisagni P, Di Carlo V. Artificial nutrition after major abdominal surgery: impact of route of administration and composition of the diet. Crit Care Med. 1998;26:24-30.
20. Senkal M, Mumme A, Eickhoff U, et al. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med. 1997;25:1489-1496.
21. Gianotti L, Braga M, Vignali A, et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg. 1997;132:1222-1230.
22. Schilling J, Vranjes N, Fierz W, et al. Clinical outcome and immunology of postoperative arginine, ω-3 fatty acids and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition. 1996;12:423-429.
23. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944-953.
24. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999;27:2799-2805.
25. Brag M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg. 2002;137:174-180.
26. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002;122:1763-1770.
27. Tepaske R, Velthuis H, Oudemans-van Straaten HM, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomized placebo-controlled trial. Lancet. 2001;358:696-701.
28. Braga M, Gianotti L, Vignali A, Di Carlo V. Preoperative oral arginine and ω-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery. 2002;132:805-814.
29. Kozar RA, McQuiggan MM, Moore FA. Nutritional support of trauma patients. In: Shikora SA, Martindale RG, Schwaitzberg SD, eds. Nutritional Considerations in the Intensive Care Unit. Dubuque, Iowa: Kendall/Hunt Publishing Co; 2002;229-244.
30. Moore FA, Moore EE, Kudsk KA, et al. Clinical benefits of an immune-enhancing diet for early post injury enteral feeding. J Trauma. 1994;37:607-615.
31. Kudsk KA, Minard G, Croce MA, et al. A randomized trial of isonitrogenous enteral diets after severe trauma: an immune-enhancing diet reduces septic complications. Ann Surg. 1996;224:531-543.
32. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med. 1995;23:436-449.
33. Weimann A, Bastian L, Bischoff WE, et al. Influence of arginine, ω-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition. 1998;14:165-172.
34. Brown RO, Hunt H, Mowatt-Larssen CA, Wojtysiak SL, Henningfield MF, Kudsk KA. Comparison of specialized and standard enteral formulas in trauma patients. Pharmacotherapy. 1994;14:314-320.
35. Mendez C, Jurkovich GJ, Garcia I, Davis D, Parker A, Maier RV. Effects of an immune-enhancing diet in critically injured patients. J Trauma. 1997;42:933-941.
36. Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med. 1999;20:303-316.
37. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312-1317.
38. Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Crit Care Med. 1998;26:1164-1172.
39. Galban C, Montejo JC, Mesejo A, et al. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med. 2000;28:643-648.
40. Montejo JC, Zarazaga A, Lopez-Martinez J, et al. Immunonutrition in the intensive care unit: a systematic review and consensus statement. Clin Nutr. 2003;22:221-233.
41. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term TPN with growth, development, and positive nitrogen balance. Surgery. 1968;64:134-142.
42. Curry CR, Quie PG. Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med. 1971;285:1221-1225.
43. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Am J Clin Nutr. 1997;66:683-706.
44. Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology. 2001;121:970-1001.
45. Braunschweig CL, Levy P, Sheean PM, Wang X. Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr. 2001;74:534-542.
46. Koretz RL. Immunonutrition: fact, fantasy, and future. Curr Gastroenterol Rep. 2002;4:332-337.
47. McCowen KC, Bistrian BR. Immunonutrition: problematic or problem solving? Am J Clin Nutr. 2003;77:764-770.
48. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative TPN in surgical patients. N Engl J Med. 1991;325:525-532.
49. Sax HC, Warner BW, Talamini MA, et al. Early TPN in acute pancreatitis: lack of beneficial effects. Am J Surg. 1987;153:117-124.
50. Rutten P, Blackburn GL, Flatt JP, Hallowell E, Cochran D. Determination of optimal hyperalimentation infusion rate. J Surg Res. 1975;18:477-483.
51. Long CL, Blakemore WS. Energy and protein requirements in the hospitalized patient. JPEN. 1979;3:69-71.
52. Quebbeman EJ, Ausman RK, Schneider TC. A re-evaluation of energy expenditure during parenteral nutrition. Ann Surg. 1982;195:282-286.
53. Hunter DC, Jaksic T, Lewis D, Benotti PN, Blackburn GL, Bistrian BR. Resting energy expenditure in the critically ill: estimations versus measurement. Br J Surg. 1988;75:875-878.
54. Baker JP, Detsky AS, Stewart S, Whitwell J, Marliss EB, Jeejeebhoy KN. Randomized trial of TPN in critically ill patients: metabolic effects of varying glucose lipid ratios as the energy source. Gastroenterology. 1984;87:53-59.
55. Paauw JD, McCamish MA, Dean RE, Quellette TR. Assessment of caloric needs in stressed patients. J Am Coll Nutr. 1984;3:51-59.
56. Mann S, Westenskow DR, Houtchens BA. Measured and predicted caloric expenditure in the acutely ill. Crit Care Med. 1985;13:173-177.
57. Foster GD, Knox LS, Dempsey DT, Mullen JL. Caloric requirements in TPN. J Am Coll Nutr. 1987;6:231-253.
58. Plevak DJ, DiCecco SR, Wiesner RH, et al. Nutritional support for liver transplantation: identifying caloric and protein requirements. Mayo Clin Proc. 1994;69:225-230.
59. McMahon MM, Farnell MB, Murray MJ. Nutritional support of critically ill patients. Mayo Clin Proc. 1993;68:911-920.
60. Chandra RK. Immunodeficiency in undernutrition and overnutrition. Nutr Rev. 1981;39:225-231.
61. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am. 1995;9:1-9.
62. Jensen GL, Mascioli EA, Seidner DL, et al. Parenteral infusion of long- and medium-chain triglycerides and reticuloendothelial system function in man. JPEN. 1990;14:467-471.
63. Keusch GT, Farthing MJ. Nutrition and infection. Annu Rev Nutr. 1986;6:131-154.
64. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg. 1999;229:467-477.
65. Halperin M, DeMets DL, Ware JH. Early methodological developments for clinical trials at the National Heart, Lung and Blood Institute. Stat Med. 1990;9:881-892.